PrEPVacc is planning to run the clinical trial at five sites in four countries:

• Masaka, Uganda

• Dar-es-Salaam, Tanzania

• Mbeya, Tanzania

• Maputo, Mozambique

• Durban, South Africa

Click on the links above for contact details for participants at each site.

Find a full list of PrEPVacc Partners here